Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 6
2005 5
2006 12
2007 6
2008 8
2009 7
2010 2
2011 2
2012 8
2013 4
2014 6
2015 5
2016 11
2017 6
2018 8
2019 8
2020 13
2021 17
2022 19
2023 18
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB.
Imai M, Ito M, Kiso M, Yamayoshi S, Uraki R, Fukushi S, Watanabe S, Suzuki T, Maeda K, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Halfmann PJ, Kawaoka Y. Imai M, et al. Among authors: fukushi s. N Engl J Med. 2023 Jan 5;388(1):89-91. doi: 10.1056/NEJMc2214302. Epub 2022 Dec 7. N Engl J Med. 2023. PMID: 36476720 Free PMC article. No abstract available.
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates.
Uraki R, Iida S, Halfmann PJ, Yamayoshi S, Hirata Y, Iwatsuki-Horimoto K, Kiso M, Ito M, Furusawa Y, Ueki H, Sakai-Tagawa Y, Kuroda M, Maemura T, Kim T, Mine S, Iwamoto N, Li R, Liu Y, Larson D, Fukushi S, Watanabe S, Maeda K, Wang Z, Ohmagari N, Theiler J, Fischer W, Korber B, Imai M, Suzuki T, Kawaoka Y. Uraki R, et al. Among authors: fukushi s. Nat Commun. 2023 Mar 23;14(1):1620. doi: 10.1038/s41467-023-37059-x. Nat Commun. 2023. PMID: 36959194 Free PMC article.
Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants.
Moriyama S, Anraku Y, Taminishi S, Adachi Y, Kuroda D, Kita S, Higuchi Y, Kirita Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y. Moriyama S, et al. Among authors: fukushi s. Nat Commun. 2023 Jul 14;14(1):4198. doi: 10.1038/s41467-023-39890-8. Nat Commun. 2023. PMID: 37452031 Free PMC article.
[Arenavirus infections].
Tani H, Fukushi S, Yoshikawa T, Saijo M, Morikawa S. Tani H, et al. Among authors: fukushi s. Uirusu. 2012;62(2):229-38. doi: 10.2222/jsv.62.229. Uirusu. 2012. PMID: 24153233 Free article. Review. Japanese.
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents.
Uraki R, Halfmann PJ, Iida S, Yamayoshi S, Furusawa Y, Kiso M, Ito M, Iwatsuki-Horimoto K, Mine S, Kuroda M, Maemura T, Sakai-Tagawa Y, Ueki H, Li R, Liu Y, Larson D, Fukushi S, Watanabe S, Maeda K, Pekosz A, Kandeil A, Webby RJ, Wang Z, Imai M, Suzuki T, Kawaoka Y. Uraki R, et al. Among authors: fukushi s. Nature. 2022 Dec;612(7940):540-545. doi: 10.1038/s41586-022-05482-7. Epub 2022 Nov 2. Nature. 2022. PMID: 36323336
Antiviral efficacy against and replicative fitness of an XBB.1.9.1 clinical isolate.
Uraki R, Ito M, Kiso M, Yamayoshi S, Iwatsuki-Horimoto K, Sakai-Tagawa Y, Imai M, Koga M, Yamamoto S, Adachi E, Saito M, Tsutsumi T, Otani A, Fukushi S, Watanabe S, Suzuki T, Kikuchi T, Yotsuyanagi H, Maeda K, Kawaoka Y. Uraki R, et al. Among authors: fukushi s. iScience. 2023 Oct 4;26(11):108147. doi: 10.1016/j.isci.2023.108147. eCollection 2023 Nov 17. iScience. 2023. PMID: 37876803 Free PMC article.
Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain.
Takano T, Sato T, Kotaki R, Moriyama S, Fukushi S, Shinoda M, Kabasawa K, Shimada N, Kousaka M, Adachi Y, Onodera T, Terahara K, Isogawa M, Matsumura T, Shinkai M, Takahashi Y. Takano T, et al. Among authors: fukushi s. Nat Commun. 2023 Mar 15;14(1):1451. doi: 10.1038/s41467-023-37128-1. Nat Commun. 2023. PMID: 36922492 Free PMC article.
CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes.
Onodera T, Sax N, Sato T, Adachi Y, Kotaki R, Inoue T, Shinnakasu R, Nakagawa T, Fukushi S, Terooatea T, Yoshikawa M, Tonouchi K, Nagakura T, Moriyama S, Matsumura T, Isogawa M, Terahara K, Takano T, Sun L, Nishiyama A, Omoto S, Shinkai M, Kurosaki T, Yamashita K, Takahashi Y. Onodera T, et al. Among authors: fukushi s. Sci Adv. 2023 Jun 16;9(24):eadf0661. doi: 10.1126/sciadv.adf0661. Epub 2023 Jun 14. Sci Adv. 2023. PMID: 37315144 Free PMC article.
Varicella Vaccine-Induced Infantile Zoster-Like Skin Rash.
Sugai T, Fujita Y, Yamada S, Fukushi S, Inamura E, Hatakeyama K, Shimizu S. Sugai T, et al. Among authors: fukushi s. J Pediatr. 2022 Dec;251:218-219. doi: 10.1016/j.jpeds.2022.08.032. Epub 2022 Aug 23. J Pediatr. 2022. PMID: 36027973 No abstract available.
The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan.
Takahashi T, Maeda K, Suzuki T, Ishido A, Shigeoka T, Tominaga T, Kamei T, Honda M, Ninomiya D, Sakai T, Senba T, Kaneyuki S, Sakaguchi S, Satoh A, Hosokawa T, Kawabe Y, Kurihara S, Izumikawa K, Kohno S, Azuma T, Suemori K, Yasukawa M, Mizutani T, Omatsu T, Katayama Y, Miyahara M, Ijuin M, Doi K, Okuda M, Umeki K, Saito T, Fukushima K, Nakajima K, Yoshikawa T, Tani H, Fukushi S, Fukuma A, Ogata M, Shimojima M, Nakajima N, Nagata N, Katano H, Fukumoto H, Sato Y, Hasegawa H, Yamagishi T, Oishi K, Kurane I, Morikawa S, Saijo M. Takahashi T, et al. Among authors: fukushi s. J Infect Dis. 2014 Mar;209(6):816-27. doi: 10.1093/infdis/jit603. Epub 2013 Nov 14. J Infect Dis. 2014. PMID: 24231186 Free PMC article.
160 results